Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of APGE will decline by -0.46% over the next 2 Weeks and hit $83.16 by Monday, May 18, 2026. In that time frame, APGE's share price is expected to range between $78.62 and $87.35.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| May 18, 2026 | 78.62 | 83.16 | 87.35 |
| May 15, 2026 | 77.67 | 82.15 | 86.55 |
| May 14, 2026 | 77.98 | 82.86 | 87.06 |
| May 13, 2026 | 78.40 | 82.61 | 87.02 |
| May 12, 2026 | 78.93 | 83.38 | 87.78 |
| May 11, 2026 | 79.06 | 83.35 | 88.08 |
| May 8, 2026 | 77.95 | 82.34 | 86.87 |
| May 7, 2026 | 78.64 | 83.05 | 87.41 |
| May 6, 2026 | 78.13 | 82.80 | 87.20 |
| May 5, 2026 | 79.32 | 83.57 | 88.02 |
APGE shares rose +3.47% in Monday, May 4, 2026's trading session, rising from a previous close of $80.75 to move at $83.55. The stock demonstrated notable intraday movement (see APGE's key stats for a full breakdown), fluctuating between $80.52 and $85.45, a +6.12% trading range. While recent weeks have seen some volatility, APGE has managed to secure a -9.38% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 567.88K shares changing hands, 49.54K more than the previous session. This amounted to $47.45M in total market activity.
Will APGE Continue Its Upward Trend?
According to analyst ratings and projections for APGE, Apogee Therapeutics, Inc. shares are anticipated to increase by +4.35%, potentially reaching $87.35 per share by May 18, 2026. Short-term technical indicators currently suggest a neutral sentiment for APGE. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the APGE stock forecast, now is a good time to buy APGE stock because its current trading price is +0.47% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on APGE covering social and institutional perspectives.
APGE Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into APGE's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 45.16% to 52.16%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 55.05%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 55.60%, maintains a neutral outlook for the long term. Insights into APGE's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Apogee Therapeutics Short-Term Forecasts
APGE Forecast For Next 5 Days
Our algorithm anticipates Apogee Therapeutics (APGE) stock could hit $76.15 by May 12, 2026. This represents a -8.85% rise from today's price, following a +5.65% change over the past five days.
APGE Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Apogee Therapeutics, Inc. (APGE) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $79.50, which would mean a -4.85% decrease from the current price of $83.55. Projections for this period range from a high of $91.25 to a low of $67.87.
APGE Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Apogee Therapeutics's price over the next three months point to a drop. APGE stock is expected to peak at $90.10 on Aug 05, 2026 after potentially dipping to $74.83 on Jul 13, 2026. On average, APGE is likely to trade around $82.79 in the coming 90 days.
Apogee Therapeutics Stock Forecast 2025
Based on our predictive models, Apogee Therapeutics (APGE) is expected to trade between $74.83 and $104.21 throughout 2026. This would result in an average price of $86.81, potentially offering investors a +3.90% return from current levels.
Apogee Therapeutics, Inc. Monthly Forecast 2026–2027
May 2026
According to our latest forecast models, Apogee Therapeutics, Inc. (APGE) is positioned to show a strong performance in May 2026. The price is predicted to move between $77.58 and $88.44, settling at an average of $83.08. This could translate to a -0.56% loss.
June 2026
Based on current market signals, Apogee Therapeutics, Inc. is projected to trend june 2026. We forecast a trading range from $77.32 to $89.83, with a likely average price of $83.73. Investors could expect a potential return of +0.22%.
July 2026
Our predictive algorithms indicate Apogee Therapeutics, Inc. stock may see a shift in July 2026. The expected range spans $74.83–$88.36, with an average target of $81.44. This represents a cautious outlook and a possible loss of -2.53%.
August 2026
Analyzing established trends, Apogee Therapeutics, Inc. looks set to move in August 2026. Projections place the stock between $79.40 and $96.15, averaging around $87.32. This suggests a +4.51% gain from current levels.
September 2026
Market indicators suggest Apogee Therapeutics, Inc. could experience notable changes during September 2026. Prices could fluctuate within $85.08 to $97.54, with a midpoint forecast of $91.96. The stock might deliver a +10.07% gain.
October 2026
Forecasting for October 2026, models estimate that Apogee Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $83.18 and $94.72, averaging $89.08. This signals a positive trajectory with potential returns around +6.62%.
November 2026
According to our latest forecast models, Apogee Therapeutics, Inc. (APGE) is positioned to show a strong performance in November 2026. The price is predicted to move between $83.64 and $104.21, settling at an average of $90.17. This could translate to a +7.92% gain.
December 2026
Based on current market signals, Apogee Therapeutics, Inc. is projected to trend december 2026. We forecast a trading range from $80.46 to $94.38, with a likely average price of $87.60. Investors could expect a potential return of +4.85%.
January 2027
Our predictive algorithms indicate Apogee Therapeutics, Inc. stock may see a shift in January 2027. The expected range spans $85.53–$102.66, with an average target of $93.97. This represents a positive outlook and a possible gain of +12.47%.
February 2027
Analyzing established trends, Apogee Therapeutics, Inc. looks set to move in February 2027. Projections place the stock between $91.50 and $103.96, averaging around $98.12. This suggests a +17.44% gain from current levels.
March 2027
Market indicators suggest Apogee Therapeutics, Inc. could experience notable changes during March 2027. Prices could fluctuate within $89.55 to $100.77, with a midpoint forecast of $95.15. The stock might deliver a +13.88% gain.
April 2027
Forecasting for April 2027, models estimate that Apogee Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $88.21 and $102.40, averaging $95.51. This signals a positive trajectory with potential returns around +14.31%.
May 2027
According to our latest forecast models, Apogee Therapeutics, Inc. (APGE) is positioned to show a strong performance in May 2027. The price is predicted to move between $88.34 and $98.42, settling at an average of $92.67. This could translate to a +10.92% gain.
APGE's history of dividends and stock splits also plays a role in long-term investor confidence.

